Format

Send to

Choose Destination
Curr Opin Drug Discov Devel. 2003 Sep;6(5):640-7.

Potassium channels as therapeutic targets for autoimmune disorders.

Author information

1
University of California, Davis Department of Pharmacology and Toxicology, School of Medicine, Tupper Hall, One Shields Avenue, Davis, CA 95616, USA.

Abstract

In human T-lymphocytes, the voltage-gated Kv1.3 channel and the Ca(2+)-activated IKCa1 channel play an important role in Ca2+ signaling, activation, adhesion and migration and have, therefore, long been regarded as attractive targets for immunotherapy. Here, we review the pharmacology of the two channels, their expression pattern in naïve and memory T-cells and their functional roles during T-cell activation, and explain the rationale for the use of Kv1.3 blockers for the therapy of T-cell mediated autoimmune diseases.

PMID:
14579513
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center